MedTrace Logo

Efficacy of Mydriatic Drops in Premature Infants

NCT03448640 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2018-02-28

No results posted yet for this study

Summary

Because of the neonatologists reported that some infants had suffered from vomiting, bradycardia, hypotonia, and aspiration risk about 30-60 minutes after the fundus examination in the intensive care unit. The investigators observed the pupil dilation effects and side effects of tipple instillation of phenylephrine 2.5% plus tropicamide 0.5% ophthalmic drop combination which the investigators routinely used in ROP examination.

Conditions

  • Retinopathy of Prematurity

Interventions

DRUG

Drug used in the examination of premature infants.

to investigate side effects of eye drops used

Sponsors & Collaborators

  • Bulent Ecevit University

    lead OTHER

Eligibility

Min Age
32 Weeks
Max Age
34 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-15
Primary Completion
2017-10-15
Completion
2017-12-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03448640 on ClinicalTrials.gov